BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7042056)

  • 21. Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations.
    Lazareno S; Birdsall NJ
    Br J Pharmacol; 1993 Aug; 109(4):1110-9. PubMed ID: 8401922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological classification of alpha 1-adrenoceptors mediating contractions of rabbit isolated ear artery: comparison with rat isolated thoracic aorta.
    Fagura MS; Lydford SJ; Dougall IG
    Br J Pharmacol; 1997 Jan; 120(2):247-58. PubMed ID: 9117117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors.
    Lanzafame A; Christopoulos A; Mitchelson F
    Eur J Pharmacol; 1996 Nov; 316(1):27-32. PubMed ID: 8982646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promiscuous or heterogeneous muscarinic receptors in rat atria? I. Schild analysis with simple competitive antagonists.
    Kenakin TP; Boselli C
    Eur J Pharmacol; 1990 Nov; 191(1):39-48. PubMed ID: 2092999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking the CGRP Receptor: Differences across Human Vascular Beds.
    de Vries T; Boucherie DM; van den Bogaerdt A; Danser AHJ; MaassenVanDenBrink A
    Pharmaceuticals (Basel); 2023 Jul; 16(8):. PubMed ID: 37630989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays.
    Roberts SP; Harper EA; Watt GF; Gerskowitch VP; Hull RA; Shankley NP; Black JW
    Br J Pharmacol; 1996 Aug; 118(7):1779-89. PubMed ID: 8842444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
    Verdoorn TA; Kleckner NW; Dingledine R
    Mol Pharmacol; 1989 Mar; 35(3):360-8. PubMed ID: 2564633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of alpha1-adrenoceptor subtypes in rabbit aorta and arteries: regional difference and co-existence.
    Satoh M; Enomoto K; Takayanagi I; Koike K
    Eur J Pharmacol; 1999 Jun; 374(2):229-40. PubMed ID: 10422764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative evaluation of the potencies of GABA-receptor agonists and antagonists using the rat hippocampal slice preparation.
    Kemp JA; Marshall GR; Woodruff GN
    Br J Pharmacol; 1986 Apr; 87(4):677-84. PubMed ID: 3011168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors.
    Kleckner NW; Dingledine R
    Mol Pharmacol; 1989 Sep; 36(3):430-6. PubMed ID: 2550776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T; Boselli C
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
    Benveniste M; Mayer ML
    Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-adrenoceptor subtypes in dog saphenous vein that mediate contraction and inositol phosphate production.
    Hicks PE; Barras M; Herman G; Mauduit P; Armstrong JM; Rossignol B
    Br J Pharmacol; 1991 Jan; 102(1):151-61. PubMed ID: 1675142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of beta-adrenoceptor subtypes in mediating relaxation of the pig bladder trigonal muscle in vitro.
    Yamanishi T; Chapple CR; Yasuda K; Yoshida K; Chess-Williams R
    Neurourol Urodyn; 2003; 22(4):338-42. PubMed ID: 12808710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots.
    Wellstein A; Belz GG; Palm D
    J Pharmacol Exp Ther; 1988 Jul; 246(1):328-37. PubMed ID: 2839668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification of phenoxybenzamine/prazosin-resistant contractions of rat spleen to norepinephrine by Schild analysis: similarities and differences to postsynaptic alpha-2 adrenoceptors.
    Kenakin TP; Novak PJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):206-12. PubMed ID: 2826768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Competitive antagonism of glutamate receptor channels by substituted benzazepines in cultured cortical neurons.
    Swartz KJ; Koroshetz WJ; Rees AH; Huettner JE
    Mol Pharmacol; 1992 Jun; 41(6):1130-41. PubMed ID: 1352036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man.
    Breithaupt-Grögler K; Malerczyk C; Belz GG; Butzer R; Herrmann V; Stass H; Wensing G
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):434-41. PubMed ID: 9352392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade.
    Martin SW; Broadley KJ
    Br J Pharmacol; 1995 May; 115(2):349-55. PubMed ID: 7670737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.